SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Mimedx Group, Inc. – ‘10-K’ for 12/31/19 – ‘EX-10.34’

On:  Monday, 7/6/20, at 6:02am ET   ·   For:  12/31/19   ·   Accession #:  1376339-20-45   ·   File #:  1-35887

Previous ‘10-K’:  ‘10-K’ on 3/17/20 for 12/31/18   ·   Next:  ‘10-K’ on 3/8/21 for 12/31/20   ·   Latest:  ‘10-K’ on 2/28/24 for 12/31/23   ·   8 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 7/06/20  Mimedx Group, Inc.                10-K       12/31/19  119:16M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.24M 
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     38K 
 3: EX-10.29    Material Contract                                   HTML     54K 
 4: EX-10.30    Material Contract                                   HTML     46K 
 5: EX-10.33    Material Contract                                   HTML     55K 
 6: EX-10.34    Material Contract                                   HTML     55K 
 7: EX-10.35    Material Contract                                   HTML     53K 
 8: EX-10.36    Material Contract                                   HTML    961K 
 9: EX-10.37    Material Contract                                   HTML     49K 
10: EX-10.38    Material Contract                                   HTML    370K 
11: EX-10.39    Material Contract                                   HTML    148K 
12: EX-21.1     Subsidiaries List                                   HTML     29K 
13: EX-23.1     Consent of Experts or Counsel                       HTML     30K 
18: EX-33       Report of Compliance with Servicing Criteria        HTML    179K 
14: EX-31.1     Certification -- §302 - SOA'02                      HTML     37K 
15: EX-31.2     Certification -- §302 - SOA'02                      HTML     37K 
16: EX-32.1     Certification -- §906 - SOA'02                      HTML     32K 
17: EX-32.2     Certification -- §906 - SOA'02                      HTML     32K 
25: R1          Cover Page                                          HTML     87K 
26: R2          Consolidated Balance Sheets                         HTML    118K 
27: R3          Consolidated Balance Sheets (Parenthetical)         HTML     51K 
28: R4          Consolidated Statements of Operations               HTML     91K 
29: R5          Consolidated Statements of Stockholders' Equity     HTML     95K 
30: R6          Consolidated Statements of Cash Flows               HTML    137K 
31: R7          Nature of Business                                  HTML     36K 
32: R8          Liquidity and Capital Resources                     HTML     40K 
33: R9          Significant Accounting Policies                     HTML    175K 
34: R10         Stability Biologics, LLC                            HTML     68K 
35: R11         Inventory                                           HTML     42K 
36: R12         Property and Equipment                              HTML     57K 
37: R13         Leases                                              HTML     60K 
38: R14         Goodwill and Intangible Assets                      HTML     89K 
39: R15         Accrued Expenses                                    HTML     45K 
40: R16         Long Term Debt                                      HTML     70K 
41: R17         Net (Loss) Income Per Share                         HTML     59K 
42: R18         Equity                                              HTML    108K 
43: R19         Income Taxes                                        HTML    169K 
44: R20         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     46K 
                Investing and Financing Activities                               
45: R21         401(k) Plan                                         HTML     34K 
46: R22         Commitments and Contingencies                       HTML    111K 
47: R23         Revenue Data by Customer Type                       HTML     48K 
48: R24         Related Party Transactions                          HTML     36K 
49: R25         Restructuring                                       HTML     41K 
50: R26         Quarterly Financial Data (Unaudited)                HTML     84K 
51: R27         Subsequent Events                                   HTML     51K 
52: R28         Schedule II - Valuation and Qualifying Accounts     HTML     71K 
53: R29         Significant Accounting Policies (Policies)          HTML    239K 
54: R30         Significant Accounting Policies (Tables)            HTML     47K 
55: R31         Stability Biologics, LLC (Tables)                   HTML     67K 
56: R32         Inventory (Tables)                                  HTML     44K 
57: R33         Property and Equipment (Tables)                     HTML     59K 
58: R34         Leases (Tables)                                     HTML     59K 
59: R35         Goodwill and Intangible Assets (Tables)             HTML    133K 
60: R36         Accrued Expenses (Tables)                           HTML     44K 
61: R37         Long Term Debt (Tables)                             HTML     55K 
62: R38         Net (Loss) Income Per Share (Tables)                HTML     70K 
63: R39         Equity (Tables)                                     HTML     96K 
64: R40         Income Taxes (Tables)                               HTML    164K 
65: R41         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     45K 
                Investing and Financing Activities (Tables)                      
66: R42         Commitments and Contingencies (Tables)              HTML     38K 
67: R43         Revenue Data by Customer Type (Tables)              HTML     46K 
68: R44         Restructuring (Tables)                              HTML     38K 
69: R45         Quarterly Financial Data (Unaudited) (Tables)       HTML     84K 
70: R46         Nature of Business (Details)                        HTML     32K 
71: R47         Liquidity and Capital Resources (Details)           HTML     40K 
72: R48         Significant Accounting Policies (Details)           HTML    109K 
73: R49         Significant Accounting Policies - Assessment of     HTML     60K 
                Revenue under ASC 606 (Details)                                  
74: R50         Stability Biologics, LLC - Narrative (Details)      HTML     81K 
75: R51         Stability Biologics, LLC - Summary of Assets        HTML    103K 
                Transferred and Consideration Received (Details)                 
76: R52         Inventory (Details)                                 HTML     44K 
77: R53         Property and Equipment - Property and Equipment     HTML     48K 
                (Details)                                                        
78: R54         Property and Equipment - Depreciation (Details)     HTML     39K 
79: R55         Leases (Details)                                    HTML     39K 
80: R56         Leases - Supplemental Balance Sheet Information     HTML     45K 
                (Details)                                                        
81: R57         Leases - Maturities of Operating Lease Liabilities  HTML     51K 
                (Details)                                                        
82: R58         Leases - Future Minimum Operating Lease Payments    HTML     49K 
                (Details)                                                        
83: R59         Goodwill and Intangible Assets - Intangible Assets  HTML     61K 
                Activity Summary (Details)                                       
84: R60         Goodwill and Intangible Assets - Narrative          HTML     41K 
                (Details)                                                        
85: R61         Goodwill and Intangible Assets - Expected Future    HTML     46K 
                Amortization of Intangible Assets (Details)                      
86: R62         Goodwill and Intangible Assets - Changes in         HTML     35K 
                Carrying Amount of Goodwill (Details)                            
87: R63         Accrued Expenses (Details)                          HTML     49K 
88: R64         Long Term Debt (Details)                            HTML     46K 
89: R65         Long Term Debt - Term Loan (Details)                HTML     58K 
90: R66         Long Term Debt - Term Loan Balances (Details)       HTML     50K 
91: R67         Long Term Debt - Term Loan Interest Expense         HTML     45K 
                (Details)                                                        
92: R68         Long Term Debt - Term Loan Maturity (Details)       HTML     50K 
93: R69         Net (Loss) Income Per Share - Computation of Basic  HTML     58K 
                and Dilutive Net Loss per Share (Details)                        
94: R70         Net (Loss) Income Per Share - Summary of            HTML     38K 
                Antidilutive Securities (Details)                                
95: R71         Equity - Narrative (Details)                        HTML    114K 
96: R72         Equity - Activity of Stock Options (Details)        HTML     77K 
97: R73         Equity - 2019 Stock Option Modification (Details)   HTML     46K 
98: R74         Equity - Summary of Restricted Stock Awards         HTML     55K 
                (Details)                                                        
99: R75         Equity - Recognized Stock-Based Compensation        HTML     44K 
                (Details)                                                        
100: R76         Income Taxes - Deferred Tax Assets and Liabilities  HTML     83K  
                (Details)                                                        
101: R77         Income Taxes - Narrative (Details)                  HTML     55K  
102: R78         Income Taxes - Reconciliation of the Federal        HTML     87K  
                Statutory Income Tax (Details)                                   
103: R79         Income Taxes - Schedule of current and deferred     HTML     58K  
                income tax expense (Benefit) (Details)                           
104: R80         Income Taxes - Reconciliation of unrecognized tax   HTML     43K  
                benefits (Details)                                               
105: R81         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     45K  
                Investing and Financing Activities (Details)                     
106: R82         401(k) Plan (Details)                               HTML     43K  
107: R83         Commitments and Contingencies - Narrative           HTML     96K  
                (Details)                                                        
108: R84         Commitments and Contingencies - Estimated Annual    HTML     42K  
                Lease, Royalty, and Employment Agreement Expenses                
                (Details)                                                        
109: R85         Revenue Data by Customer Type (Details)             HTML     47K  
110: R86         Related Party Transactions (Details)                HTML     43K  
111: R87         Restructuring - Narrative (Details)                 HTML     37K  
112: R88         Restructuring - Restructuring Reserve Liability     HTML     39K  
                (Details)                                                        
113: R89         Quarterly Financial Data (Unaudited) (Details)      HTML     58K  
114: R90         Subsequent Events (Details)                         HTML    144K  
115: R91         Schedule II - Valuation and Qualifying Accounts     HTML     42K  
                (Details)                                                        
117: XML         IDEA XML File -- Filing Summary                      XML    199K  
24: XML         XBRL Instance -- a2019annual10-k_htm                 XML   2.68M 
116: EXCEL       IDEA Workbook of Financial Reports                  XLSX    153K  
20: EX-101.CAL  XBRL Calculations -- mdxg-20191231_cal               XML    358K 
21: EX-101.DEF  XBRL Definitions -- mdxg-20191231_def                XML    705K 
22: EX-101.LAB  XBRL Labels -- mdxg-20191231_lab                     XML   2.21M 
23: EX-101.PRE  XBRL Presentations -- mdxg-20191231_pre              XML   1.27M 
19: EX-101.SCH  XBRL Schema -- mdxg-20191231                         XSD    204K 
118: JSON        XBRL Instance as JSON Data -- MetaLinks              478±   697K  
119: ZIP         XBRL Zipped Folder -- 0001376339-20-000045-xbrl      Zip    913K  


‘EX-10.34’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  

Exhibit 10.34
MIMEDX GROUP, INC.

2016 EQUITY AND CASH INCENTIVE PLAN
Employee Performance-Vested Restricted Stock Unit Agreement    
THIS RESTRICTED STOCK UNIT AGREEMENT (this "Agreement") dated as of the ___ day of                 , 20___ (the “Grant Date”), between MiMedx Group, Inc. (the "Company") and _________________ (the "Participant"), is made pursuant and subject to the provisions of the Company's 2016 Equity and Cash Incentive Plan (the "Plan"), a copy of which is attached hereto. All terms used herein that are defined in the Plan shall have the same meaning given them in the Plan.
1.Grant of Restricted Stock Units.
(a)    Pursuant to the Plan, the Company, on the Grant Date granted to the Participant, subject to the terms and conditions of the Plan and subject further to the terms and conditions set forth herein, this Restricted Stock Unit Award with a value of $_____ (the “Award Value”).
(b)    The number of restricted stock units (“RSUs”) shall be determined by dividing the Award Value by the closing stock price of the Company on the Determination Date.
(c)    The “Determination Date” shall mean the date that is 30 calendar days following the date on which the Company has both (x) filed with the United States Securities and Exchange Commission its audited financial statements for the fiscal year ending December 31, 2019, and (y) has otherwise become current with all other applicable filing requirements of the SEC or has been excused therefrom.
(d)    Each RSU represents the right to receive one share of Common Stock (a "Share"). The RSUs will vest as set forth in Section 2 below and, upon vesting, will be settled as set forth in Section 3 below.
2.    Vesting of the RSUs. Subject to earlier expiration, termination or vesting as provided herein, the RSUs will vest as follows:
(a)    Performance-Based Vesting. The RSUs will vest and be nonforfeitable upon the attainment of all of the criteria set forth on Exhibit A attached hereto, provided that the Participant has been continuously employed by, or providing services to, the Company or an Affiliate of the Company from the Grant Date until such time(s) (the “Vesting Date”).
(b)    Change in Control. Notwithstanding the foregoing, upon the occurrence of a Change in Control, the RSUs shall become fully vested at the time of the Change in Control, provided the Participant has been continuously providing services as an employee of the Company from the Grant Date until the time of the Change in Control. For purposes of this Agreement, “Vesting Date” shall be deemed to include the date upon which a Change in Control occurs.
(c)    Death and Disability. Additionally, if the Participant's service as an employee of the Company is terminated on account of the Participant's death or Disability, the RSUs shall become fully vested upon termination of the Participant's service as an employee of the Company on account of the Participant's death or Disability. For purposes of his Agreement, “Vesting Date” shall be deemed to include

1



the date of termination of the Participant’s service as an employee of the Company on account of the Participant’s death or Disability.
3.    Settlement of RSUs.
(a)    Except as otherwise required by applicable law or as set forth below or in the Plan, the Company shall cause one Share to be issued to the Participant for each RSU that vests upon an applicable Vesting Date, with such Shares to be delivered to the Participant within forty-five (45) days after the applicable Determination Date.
(b)    Except as set forth in Section 4(e) below, in the event that the Company is unable to settle any vested RSUs in Shares within forty-five (45) days after the later of the Determination Date and the Vesting Date, the Company shall cause any such RSUs that vest to be settled in cash by the delivery to the Participant of a cash payment equal to the initial Award Value (or portion thereof) as soon as administratively practicable after the later of such Determination Date or Vesting Date.
4.    Non-Transferability of the RSUs; Securities Law Compliance.
(a)    Transfer Restrictions. The Participant shall not assign or transfer any RSUs other than by will or the laws of descent and distribution. No right or interest of the Participant or any transferee in the RSUs shall be subject to any lien or any obligation or liability of the Participant or any transferee.
(b)    Investment Intent. The Participant represents and warrants to the Company that the Shares that the Participant may acquire in respect of the RSUs would be acquired only for investment and without any present intention to sell or distribute such Shares.
(c)    Securities Law Compliance. The Participant acknowledges that neither the grant of these RSUs nor the delivery of Shares, if any, upon the vesting of any RSUs has been or will be registered under the Securities Act of 1933, as amended. Notwithstanding any other provision of this Agreement or the Plan, the Participant may not sell or otherwise transfer any Shares acquired in respect of the RSUs unless the sale of such Shares is registered under the Securities Act of 1933, as amended, or unless an exemption from such registration requirement exists and the Participant provides a prior opinion of counsel acceptable to the Company as to the existence of such exemption.
(d)    Legend. The Participant understands and agrees that the certificate representing any Shares acquired in respect of the RSUs shall bear a restrictive legend as follows: “The shares represented by this certificate have not been registered under the Securities Act of 1933, as amended. The shares have been acquired for investment and may not be offered, sold or otherwise transferred in the absence of an effective registration statement with respect to the shares or an exemption from the registration requirement of said act that is then applicable to the shares, as to which a prior opinion of counsel acceptable to the issuer or transfer agent may be required.”
(e)    Delivery of Shares. The Company may postpone the delivery of any Shares issuable to the Participant in respect of the RSUs for so long as the Company determines to be necessary or advisable to satisfy the following: (1) compliance of such Shares with any applicable securities law requirements; (2) compliance with any requests for representations; and (3) receipt of proof satisfactory to the Company that a person seeking such Shares on the Participant's behalf upon the Participant's Disability or upon the Participant's estate's behalf after the death of the Participant, is appropriately authorized. Notwithstanding any other provision of the Plan or any agreement entered into by the Company pursuant to the Plan, the

2



Company shall not be obligated, and shall have no liability for failure, to issue or deliver any Shares under the Plan unless such issuance or delivery would comply with applicable state and federal securities laws, with such compliance determined by the Company in consultation with its legal counsel.
(f)    Stock Holding Requirements. Notwithstanding any other provision of this Agreement, the Shares that may be acquired by the Participant in respect of the RSUs may not be sold, transferred or otherwise disposed of until the level of ownership provided in the Company’s Stock Ownership Guidelines is met, to the extent applicable to the Participant. All Shares acquired hereunder (“net” any Shares deducted for withholding) shall be subject to the terms and conditions of the Company’s Stock Ownership Guidelines, as they may be amended from time to time.
5.    Forfeiture of the RSUs. RSUs that do not vest pursuant to Sections 2(a), (b) or (c) as of the date of termination of the Participant’s service as an employee of the Company will be forfeited automatically at the close of business on that date (or immediately upon notice of termination for Cause). In no event may RSUs vest, in whole or in part, after forfeiture pursuant to this Section 5.
6.    Agreement to Terms of the Plan and this Agreement. The Participant has received a copy of the Plan, has read and understands the terms of the Plan and this Agreement, and agrees to be bound by their terms and conditions. All decisions and interpretations made by the Company or the Committee with regard to any question arising under this Agreement will be binding and conclusive on the Company and the Participant and any other person who has any rights under this Agreement.
7.    Tax Consequences. The Participant acknowledges (i) that there may be adverse tax consequences upon acquisition or disposition of the Shares or, if applicable, cash payment that may be received upon vesting of the RSUs and (ii) that the Participant should consult a tax adviser prior to such acquisition or disposition. The Participant is solely responsible for determining the tax consequences of the Restricted Stock Unit Award and for satisfying the Participant’s tax obligations with respect to the Restricted Stock Unit Award (including, but not limited to, any income or excise tax as resulting from the application of Code Sections 409A or 4999 or related interest and penalties), and the Company and its Affiliates shall not be liable if this grant is subject to Code Sections 409A, 280G or 4999.
8.    Fractional Shares. Fractional Shares shall not be issuable hereunder, and when any provision hereof may entitle the Participant to a fractional Share such fractional Share shall be disregarded.
9.    Change in Capital Structure. The RSUs shall be adjusted in accordance with the terms and conditions of the Plan as the Committee determines is equitably required in the event the Company effects one or more stock dividends, stock splits, subdivisions or consolidations of shares or other similar changes in capitalization.
10.    Notice. Any notice or other communication given pursuant to this Agreement, or in any way with respect to the RSUs, shall be in writing and shall be personally delivered or mailed by United States registered or certified mail, postage prepaid, return receipt requested, to the following addresses:
If to the Company:    MiMedx Group, Inc.
1775 West Oak Commons Ct. NE
Marietta, Georgia 30062
Attn: General Counsel

If to the Participant:    ___________________________

3



___________________________
___________________________

11.    Shareholder Rights. Except as provided below, the Participant shall have no rights as a shareholder of the Company with respect to Shares underlying the RSUs unless and until Shares are delivered to the Participant in respect of such RSUs upon vesting. Notwithstanding the above, if dividends are paid on Shares represented by the RSUs that have not yet either vested or been forfeited:
(a)    If such dividends are cash dividends, the Company shall accumulate amounts equivalent to the amount of such dividends and pay to the Participant such amount upon distribution of the underlying Shares (or cash payment in respect of such Shares, if applicable) to the Participant in accordance with this Agreement; and
(b)    If such dividends are Share dividends, the Company shall credit the Participant with a number of additional RSUs equal to the number of dividend Shares that would have been paid to the Participant if the Participant’s RSUs had been Shares, with such additional RSUs being subject to the same terms and conditions as the RSUs to which such dividend credits relate (including with respect to vesting and settlement).
For the avoidance of doubt, if the Participant receives a cash payment in respect of vested RSUs pursuant to Section 3(b) above, the Participant shall have no rights as a shareholder of the Company with respect to the Shares that were previously underlying such vested RSUs.
12.    No Right to Continued Service. Neither the Plan, the granting of the RSUs nor any other action taken pursuant to the Plan or this Agreement constitutes or is evidence of any agreement or understanding, expressed or implied, that the Company or any Affiliate shall retain the Participant as a service provider for any period of time or at any particular rate of compensation.
13.    Binding Effect. Subject to the limitations stated above and in the Plan, this Agreement shall be binding upon and inure to the benefit of the legatees, distributees, and personal representatives of the Participant and the successors of the Company.
14.    Conflicts. In the event of any conflict between the provisions of the Plan and the provisions of this Agreement, the provisions of the Plan shall govern. All references herein to the Plan shall mean the Plan as in effect on the date hereof.
15.    Counterparts. This Agreement may be executed in a number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one in the same instrument.
16.    Miscellaneous. The parties agree to execute such further instruments and take such further actions as may be necessary to carry out the intent of the Plan and this Agreement. This Agreement and the Plan shall constitute the entire agreement of the parties with respect to the subject matter hereof.
17.    Section 409A. Notwithstanding any of the provisions of this Agreement, it is intended that the RSUs granted pursuant to this Agreement be exempt from Section 409A of the Code as short-term deferrals, pursuant to Treasury regulation §1.409A-1(b)(4), or otherwise comply with Section 409A of the Code. Notwithstanding the preceding, neither the Company nor any Affiliate shall be liable to the Participant or any other person if the Internal Revenue Service or any court or other authority have any jurisdiction over such matter determines for any reason that the RSUs are subject to taxes, penalties or interest as a result of

4



failing to be exempt from, or comply with, Section 409A of the Code. For the avoidance of doubt, the provisions of this Agreement shall be construed and interpreted consistent with Article XXII of the Plan.
18.    Compensation Recoupment Policy. Notwithstanding any other provision of this Agreement, the rights, payments and benefits with respect to the RSUs (including any amounts received by the Participant in connection with a sale of Shares received upon the vesting of RSUs) shall be subject to reduction, reimbursement, cancellation, forfeiture, recoupment or return by the Company, to the extent any reduction, reimbursement, cancellation, forfeiture, recoupment or return is required under applicable law or the Company’s Compensation Recoupment Policy or any similar policy that the Company may adopt.
19.    Governing Law. This Agreement shall be governed by the governing laws applicable to the Plan.

[Signature Page to Follow]

5




IN WITNESS WHEREOF, the Company has caused this Agreement to be signed by a duly authorized officer, and the Participant has affixed the Participant’s signature hereto.

COMPANY:
MIMEDX GROUP, INC.
By:__________________________________________
Name:________________________________________
Title:_________________________________________
PARTICIPANT:
_____________________________________________
[Participant’s Name]

 

6




Exhibit A

(performance criterion/criteria)

7


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:7/6/2010-Q,  4,  8-K
For Period end:12/31/19DEF 14A
 List all Filings 


8 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/24  Mimedx Group, Inc.                10-K       12/31/23  116:11M
 2/28/23  Mimedx Group, Inc.                10-K       12/31/22  123:13M
 2/28/22  Mimedx Group, Inc.                10-K       12/31/21  112:13M
 3/08/21  Mimedx Group, Inc.                10-K       12/31/20  111:12M
12/17/20  Mimedx Group, Inc.                S-8        12/17/20    5:422K                                   Donnelley … Solutions/FA
11/04/20  Mimedx Group, Inc.                10-Q        9/30/20   79:7.4M
11/02/20  Mimedx Group, Inc.                8-A12B                 1:37K
 8/04/20  Mimedx Group, Inc.                10-Q        6/30/20   71:5.9M
Top
Filing Submission 0001376339-20-000045   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., May 4, 6:16:29.1pm ET